跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VELTASSA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VELTASSA
Authorized
STANDARD
VELTASSA
vifor fresenius medical care renal pharma ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
af064dbab353f84c
Company
vifor fresenius medical care renal pharma ltd
Type
Standard
Approval Details
Approval Id
af064dbab353f84c
Drug Approval Canada Name
VELTASSA
Product Name
VELTASSA
Status
Marketed
Status Date
2020-03-09
Original Market Date
2020-03-09
Din
02481359
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:18.18
Atc Original
V03AE09 PATIROMER CALCIUM
Atc Name
v 03 ae 09
Aig Number
0160711001
Company Name
vifor fresenius medical care renal pharma ltd
Company Address
Rechenstrasse 37, St Gallen, St Gallen, Switzerland, 9014
Active Ingredients
PATIROMER (PATIROMER SORBITEX CALCIUM)
8.4 G / SACHET
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
af064dbab353f84c
Type
Standard
Back to Health Canada Approvals